Korean J Dermatol.  2010 Oct;48(10):884-888.

Iatrogenic Kaposi's Sarcoma Induced by Corticosteroid and That Presented as Various Clinical Forms

Affiliations
  • 1Department of Dermatology, Chonnam National University Medical School, Gwangju, Korea. yhwon@chonnam.ac.kr

Abstract

Kaposi's sarcoma (KS) is a multifocal, systemic tumor of an endothelial cell origin and there are four clinical subtypes. Among these clinical subtypes, KS associated with immunosuppressive therapy mainly develops in organ transplant patients as well as in other patients who are receiving immunosuppressants for other reasons. It can occur from 1 month to more than 10 years after starting the agent and it seems to depend on the dose and type of the drug taken. We report here on a case of diffuse cutaneous iatrogenic Kaposi's sarcoma that was associated with 2 years of oral corticosteroid therapy. The patient's disease was present as various forms of cutaneous lesions without any systemic involvement.

Keyword

Corticosteroid; Iatrogenic; Kaposi's sarcoma

MeSH Terms

Endothelial Cells
Humans
Immunosuppressive Agents
Sarcoma, Kaposi
Transplants
Immunosuppressive Agents
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr